Centre for Liver Research, Institute of Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, 5th Floor, Birmingham, B15 2TT, UK.
University Hospitals Birmingham NHS Foundation Trust, Mindelsohn Way, Birmingham, B15 2TH, UK.
J Gastroenterol. 2017 Nov;52(11):1192-1200. doi: 10.1007/s00535-017-1336-z. Epub 2017 Apr 7.
Previous studies have described the clinical impact of infection in alcoholic hepatitis (AH) but none have comprehensively explored the aetiopathogenesis of infection in this setting. We examined the causes, consequences and treatment of infection in a cohort of patients with AH.
We undertook a retrospective cohort study of patients with AH admitted between 2009 and 2014 to seven centres in Europe and the USA. Clinical and microbiological data were extracted from medical records. Survival was analysed with Kaplan-Meier analysis and Cox proportional hazards analysis to control the data for competing factors. Propensity score matching was used to examine the efficacy of prophylactic antibiotics administered in the absence of infection.
We identified 404 patients with AH. Of these, 199 (49%) showed clinical or culture evidence of infection. Gut commensal bacteria, particularly Escherichia coli and Enterobacter species, were most commonly isolated in culture. Fungal infection was rarely seen. Cultured organisms and antibiotic resistance differed markedly between centres. Infection was an independent risk factor for death (hazard ratio for death at 90 days 2.33, 95% confidence interval 1.63-3.35, p < 0.001). Initiation of antibiotic therapy on admission in the absence of infection did not reduce mortality or alter the incidence of subsequent infections. Corticosteroid use increased the incidence of infection but this did not impact on survival.
In this large real-world cohort of patients with AH, infection was common and was associated with reduced short-term survival. Gram-negative, gut commensal bacteria were the predominant infective organisms, consistent with increased translocation of gut bacteria in AH; however, the characteristics of infection differ between centres. Infection should be actively sought and treated, but we saw no benefits of prophylactic antibiotics.
先前的研究描述了感染对酒精性肝炎(AH)的临床影响,但没有一项研究全面探讨了这种情况下感染的病因发病机制。我们研究了一组 AH 患者感染的原因、后果和治疗方法。
我们对 2009 年至 2014 年间欧洲和美国的 7 个中心收治的 AH 患者进行了回顾性队列研究。从病历中提取临床和微生物学数据。采用 Kaplan-Meier 分析和 Cox 比例风险分析对生存数据进行分析,以控制数据中的竞争因素。采用倾向评分匹配来检验在无感染情况下预防性使用抗生素的疗效。
我们确定了 404 例 AH 患者。其中 199 例(49%)表现出临床或培养证据的感染。在培养中最常分离出肠道共生细菌,特别是大肠杆菌和肠杆菌属。真菌感染很少见。培养出的病原体和抗生素耐药性在各中心之间有显著差异。感染是死亡的独立危险因素(90 天死亡率的危险比为 2.33,95%置信区间 1.63-3.35,p<0.001)。在无感染的情况下,入院时开始使用抗生素治疗并未降低死亡率或改变随后感染的发生率。皮质类固醇的使用增加了感染的发生率,但并未影响生存。
在这一大规模真实世界的 AH 患者队列中,感染很常见,与短期生存率降低有关。革兰氏阴性、肠道共生细菌是主要的感染病原体,与 AH 中肠道细菌易位增加一致;然而,感染的特征在各中心之间存在差异。应积极寻找和治疗感染,但我们未发现预防性使用抗生素的益处。